DLAT and hepatocellular carcinoma: Conversely, maternal embryonic leucine zipper kinase (MELK) promotes HCC progression by activating the PI3K/mTOR signaling pathway, which promotes the expression of DLAT and thereby inhibits cuproptosis [114].